Roshni Kulkarni

Professor & Former Director
Michigan State University Centers for Bleeding and Clotting Disorders
East Lansing, United States

Dr. Kulkarni is currently Professor Emerita of Pediatrics and Human Development and Director Emerita of the Michigan State University (MSU) Center for Bleeding and Clotting Disorders and was the founder and Director emerita of Pediatric and Adolescent Hematology/Oncology (PHO). She was the Director and distinguished Hematology Consultant, Division of Blood Disorders, at the Centers for Disease Control and Prevention (CDC), Atlanta GA. She is widely published and is a founding member of the Foundation for Women and Girls with Blood Disorders (FWGBD)as well as past board member of HTRS and holds membership on numerous national, international and federal committees. She has received numerous awards including the Hemostasis and Thrombosis Research Society 2023, Lifetime Achievement Award, named one of the “Women in Medicine” by FWGBD, "Eternal Spirit” award from Coalition for Hemophilia B, “Fairy Godmother to women with Hemophilia” by Hemophilia Foundation of Michigan, National Hemophilia Foundations (NHF’s) “Physician of the Year” in 2003 and Lifetime Achievement Award in 2008, the MSU “Distinguished Faculty” award, and distinguished service awards from the Federal Drug Administration (FDA) and CDC. In 2016, she was honored as one of the “Women Leaders in Hematology” in the American Journal of Hematology.

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.